2020 Germany Cancer Diagnostics Market: Supplier Shares and Strategies by Test, Volume and Sales Segment Forecasts, Emerging Tumor Markers, Technologies and Instrumentation

2020 Germany Cancer Diagnostics Market: Supplier Shares and Strategies by Test, Volume and Sales Segment Forecasts, Emerging Tumor Markers, Technologies and Instrumentation

  • March 2020 •
  • 585 pages •
  • Report ID: 5873533 •
  • Format: PDF
2020 Germany Cancer Diagnostics Market: Supplier Shares and Strategies by Test, Volume and Sales Segment Forecasts, Emerging Tumor Markers, Technologies and Instrumentation

This new report is a study of the major business opportunities emerging in the German cancer diagnostics market during the next five years.  The report examines trends in the German cancer diagnostics markets, reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Companies Profiled
Company Assessments

- Abbott
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Clinical Genomics
- Decode Genetics
- DiaSorin
- Diazyme
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Epigenomics
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic
- Janssen Diagnostics
- Kyowa Medex
- Leica Biosystems
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- PerkinElmer
- Polymedco
- Qiagen
- Quest Diagnostics
- Roche
- Scienion
- Sequenom
- Siemens Healthineers
- Takara Bio
- Theradiag
- Thermo Fisher
- Tosoh
- Vermillion
- Wako Pure Chemicals